#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic candida Dermatitis Oesophageal atresia Rosai-Dorfman syndrome Frostbite Thrombotic thrombocytopenic purpura Liver transplant rejection Sickle cell anaemia Inborn error of metabolism Encephalopathy neonatal Von Willebrand's disease T-cell lymphoma Non-small cell lung cancer metastatic Follicular lymphoma Rhabdoid tumour More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Trials in Disease Mantle cell lymphoma refractory – Treatment Idiopathic inflammatory myopathy Sarcoma Hereditary hypophosphataemic rickets – Treatment Leiomyosarcoma metastatic – Treatment Chondrosarcoma Malignant fibrous histiocytoma – Basic Information Arterial tortuosity syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Venetoclax Lysine Acetate Betamethasone Dipropionate Ecoo1A Cctx-001 Adrenaline Acid Tartrate Bp N-Tec Gadobenate Dimeglumine Sabirnetug Inupadenant Hydrochloride Acoramidis Hydrochloride Poractant Alfa JNJ-75276617 Etuvetidigene Autotemcel VX-407 Kan-101 Metoclopramide Fosfomycin BMS-986365 Oteracil More therapies…

    Learn about Your Condition

    Enteritis Apheresis Pulmonary embolism Thromboangiitis obliterans Labour induction Adrenal insufficiency Shock Adrenocortical carcinoma Peripheral spondyloarthritis Angiosarcoma recurrent Anal fistula Device related infection Acute cardiac event Eye pain Myotonic dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Astrocytoma malignant

  • Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

    Recruiting

    3 1
    Investigated Drugs:
    • Vorasidenib
    Austria Belgium Czechia France Germany Italy +2
  • Study on the Safety of Aminolevulinic Acid with Ultrasound Therapy for Patients with Newly Diagnosed High-Grade Glioma Before Surgery and Standard Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Astrocytoma malignant
    • Malignant oligodendroglioma
    • Glioblastoma
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!